Migraines and Serotonin: The Neurovascular Connection
Serotonin’s Role in Migraine Pathophysiology
Serotonin (5-hydroxytryptamine, 5-HT) is a key neurotransmitter implicated in migraine onset, progression, and treatment.
The Serotonin Hypothesis
- During attacks: Brain serotonin levels drop. This may trigger trigeminal nerve activation, release of CGRP/substance P, neurogenic inflammation, and vasodilation of meningeal vessels → pain.
- Between attacks: Serotonergic tone may be dysregulated, lowering migraine threshold.
- Genetic links: Polymorphisms in serotonin transporter (SERT), 5-HT1F, 5-HT1B receptors associate with migraine susceptibility.
How Migraine Medications Target Serotonin
| Class | Examples | Mechanism |
|---|---|---|
| Triptans (acute) | Sumatriptan, rizatriptan, eletriptan | 5-HT1B/1D agonists → constrict meningeal vessels, inhibit CGRP release, block pain transmission |
| Gepants (acute/preventive) | Ubrogepant, rimegepant, atogepant | CGRP receptor antagonists – downstream of serotonin pathway |
| Ditans (acute) | Lasmiditan | 5-HT1F agonist – no vasoconstriction |
| Preventives (some) | Amitriptyline, venlafaxine, propranolol | Modulate serotonergic/noradrenergic tone |
